Literature DB >> 31700913

Platelet-derived microparticles promote phagocytosis of oxidized low-density lipoprotein by macrophages, potentially enhancing foam cell formation.

Can Feng1,2, Qi Chen3, Min Fan2, Jun Guo1, Yu Liu4, Tao Ji5, Jiaqi Zhu1, Xianxian Zhao1.   

Abstract

BACKGROUND: The interaction between platelets and macrophages plays an important role in the development and progression of atherosclerosis (AS). This study aimed to investigate the role of platelet microparticles (PMPs) in the development of foam cells.
METHODS: PMPs are generated by activating platelets with thrombin and separated by ultracentrifugation. The macrophages were treated with PMPs, the phagocytosis of oxidized low-density lipoprotein (Ox-LDL) and formation of foam cells were evaluated by flow cytometry and confocal microscopy, respectively, and the inflammatory factors cytokines in the supernatant were detected by ELISA.
RESULTS: PMPs significantly increase the phagocytosis of Ox-LDL and elevated foam cell formation of macrophages. IL-1β content in the supernatant of macrophages peaked around 2-4 h and declined to normal level after 6-8 h; IL-6 content peaked at 4 h and then decreased to normal level. TNF-α content peaked at 2-4 h.
CONCLUSIONS: The microparticles from activated platelets can increase the phagocytosis of Ox-LDL and the production of inflammatory cytokines by macrophages, which is related to the development of AS. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Platelets; coronary atherosclerosis disease; macrophages; microparticles

Year:  2019        PMID: 31700913      PMCID: PMC6803225          DOI: 10.21037/atm.2019.08.06

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  27 in total

1.  Platelets amplify inflammation in arthritis via collagen-dependent microparticle production.

Authors:  Eric Boilard; Peter A Nigrovic; Katherine Larabee; Gerald F M Watts; Jonathan S Coblyn; Michael E Weinblatt; Elena M Massarotti; Eileen Remold-O'Donnell; Richard W Farndale; Jerry Ware; David M Lee
Journal:  Science       Date:  2010-01-29       Impact factor: 47.728

2.  Platelet microparticles reprogram macrophage gene expression and function.

Authors:  Benoit Laffont; Aurélie Corduan; Matthieu Rousseau; Anne-Claire Duchez; Chan Ho C Lee; Eric Boilard; Patrick Provost
Journal:  Thromb Haemost       Date:  2015-09-03       Impact factor: 5.249

3.  [Association of Elevated Platelet Microparticles with Disease Activity in Rheumatoid Arthritis].

Authors:  Li-Jia Xue; Bei-Bei Cui; Xi Li; Qiao-Rong Huang; Yi Liu; Hui Lin
Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban       Date:  2017-05

4.  Platelets release proinflammatory microparticles in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Di Miao; Tian-Tian Ma; Min Chen; Ming-Hui Zhao
Journal:  Rheumatology (Oxford)       Date:  2019-03-06       Impact factor: 7.580

Review 5.  Possible roles of platelet-derived microparticles in atherosclerosis.

Authors:  Zhi-Ting Wang; Zi Wang; Yan-Wei Hu
Journal:  Atherosclerosis       Date:  2016-03-04       Impact factor: 5.162

Review 6.  Platelet-derived microparticles analysis: Techniques, challenges and recommendations.

Authors:  Jyotsna Kailashiya
Journal:  Anal Biochem       Date:  2018-02-02       Impact factor: 3.365

7.  Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA.

Authors:  Anne-Claire Duchez; Luc H Boudreau; Gajendra S Naika; James Bollinger; Clémence Belleannée; Nathalie Cloutier; Benoit Laffont; Raifish E Mendoza-Villarroel; Tania Lévesque; Emmanuelle Rollet-Labelle; Matthieu Rousseau; Isabelle Allaeys; Jacques J Tremblay; Patrice E Poubelle; Gérard Lambeau; Marc Pouliot; Patrick Provost; Denis Soulet; Michael H Gelb; Eric Boilard
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-23       Impact factor: 11.205

8.  Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis.

Authors:  Fu-Ju Tian; Li-Na An; Guo-Kun Wang; Jia-Qi Zhu; Qing Li; Ying-Ying Zhang; An Zeng; Jun Zou; Rong-Fang Zhu; Xiao-Shuai Han; Nan Shen; Huang-Tian Yang; Xian-Xian Zhao; Shuang Huang; Yong-Wen Qin; Qing Jing
Journal:  Cardiovasc Res       Date:  2014-03-27       Impact factor: 10.787

9.  Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism.

Authors:  M Merten; R Pakala; P Thiagarajan; C R Benedict
Journal:  Circulation       Date:  1999-05-18       Impact factor: 29.690

Review 10.  Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.

Authors:  Olivier Morel; Nicolas Morel; Jean-Marie Freyssinet; Florence Toti
Journal:  Platelets       Date:  2008-02       Impact factor: 3.862

View more
  5 in total

Review 1.  Role of Extracellular Vesicles in the Pathogenesis of Vascular Damage.

Authors:  Fabrizio Buffolo; Silvia Monticone; Giovanni Camussi; Elena Aikawa
Journal:  Hypertension       Date:  2022-02-11       Impact factor: 9.897

Review 2.  Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis.

Authors:  Rosa Suades; Maria Francesca Greco; Teresa Padró; Lina Badimon
Journal:  Cells       Date:  2022-06-05       Impact factor: 7.666

Review 3.  Extracellular Vesicles, Inflammation, and Cardiovascular Disease.

Authors:  Akbarshakh Akhmerov; Tanyalak Parimon
Journal:  Cells       Date:  2022-07-18       Impact factor: 7.666

Review 4.  Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis.

Authors:  Adriana Georgescu; Maya Simionescu
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 5.  Antiplatelet Effects of PCSK9 Inhibitors in Primary Hypercholesterolemia.

Authors:  Piotr Pęczek; Mateusz Leśniewski; Tomasz Mazurek; Lukasz Szarpak; Krzysztof J Filipiak; Aleksandra Gąsecka
Journal:  Life (Basel)       Date:  2021-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.